The real revolution came in 2012, when researchers Jennifer Doudna and Emmanuelle Charpentier harnessed CRISPR, a natural bacterial defense system. In bacteria, CRISPR cuts out invading viruses’ DNA ...

By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...

A study of mosquitoes’ circadian rhythms finds they hunt differently at different times of day. It could help stop their ...

Researchers have developed the first bioengineered human bone-marrow model to test CAR T-cell therapies for ­acute myeloid ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

Ecuadorian scientists are developing a biotechnological strategy to stop banana wilt by genetically editing the causative ...

In biotech, success often begins in the lab — and for CRISPR pioneers, every clinical trial feels like a moonshot.

According to the 13F filing with the Securities and Exchange Commission dated Nov. 12, 2025, ARK Investment Management sold ...

Ineos is in negotiations with its partner, the Chinese state-owned oil and chemical company Sinopec, to exit their ...